Expression of cyclin A and D proteins in prostate cancer and their relation to clinopathological variables and patient survival

Prostate

Volumn 38, Issue 3, 1999, Pages 175-182

  Aaltomaa, S ^a   Eskelinen, M ^a   Lipponen, P ^b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Cell proliferation; Cyclin A; Cyclin D; Prognosis; Prostate carcinoma

Indexed keywords

CYCLIN A; CYCLIN D; KI 67 ANTIGEN; PROTEIN BCL 2;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE PHASE; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MITOSIS INDEX; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROTEIN EXPRESSION;

EID: 0033557245     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0045(19990215)38:3<175::aid-pros1>3.0.co;2-%23     Document Type: Article

References (30)

1. Vesalainen S, Lipponen P, Talja M, Syrjänen K. Mitotic activity and prognosis in prostatic adenocarcinoma. Prostate 1995;26:80-86.
2. Vesalainen S, Nordling P, Lipponen P, Talja M, Syrjänen K. Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy. Br J Cancer 1994;70:309-314.
3. Aaltomaa S, Lipponen P, Vesalainen S, Ala-Opas M, Eskelinen M, Syrjänen K. Value of Ki-67 immunolabelling as a prognostic factor in prostate cancer. Eur Urol 1997;32:410-415.
4. Strauss M, Lukas J, Bartek J. Unrestricted cell cycling and cancer. Recent data suggest that de-regulation of the restriction point in the cell-cycle G1 phase appears to be required for the development of neoplasia. Nat Med 1995;1:1245-1246.
5. Kato JY. Control of G1 progression by D-type cyclins: key event for cell proliferation. Leukemia 1997;3:347-351.
6. Dirks PB, Rutka JT. Current concepts in neuro-oncology: the cell cycle - a review. Neurosurgery 1997;40:1000-1013.
7. Brechot C: Oncogenic activation of cyclin A. Curr Opin Genet Dev 1993;3:11-18.
8. Altucci L, Addeo R, Cicatiello L, Dauvois S, Parker MG, Truss M, Beato Sica MV, Breasciani F, Weiz A. 17 beta-estradiol induces cyclin D-1 gene transcription, p36(D1)-p34(cdk4) complex activation and p105(Rb) phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer. Oncogene 1996;12:2315-2324.
9. Peters G, Parry D, Hara E, Hall M, Bates S, Palmero I. Regulation and function of the cyclin-dependent kinase inhibitor p16CDKN2. Leukemia 1997;3:352-355.
10. Gong J, Traganos F, Darzynkiewicz Z. Discrimination of G2 and mitotic cells by flow cytometry based on different expression of cyclins A and B1. Exp Cell Res 1995;220:226-231.
11. Van Diest PJ, Michalides RJ, Jannink L, van der Valk P, Peterse HL, de Jong JS, Meijer CL, Baak JP. Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value. Am J Pathol 1997;11:492-503.
12. Shin KY, Kong G, Kim WS, Lee TY, Woo YN, Lee JD. Over-expression of cyclin D1 correlates with early recurrence in superficial bladder cancer. Br J Cancer 1997;75:1788-1792.
13. Mate JL, Ariza A, Aracil C, Lopez D, Isamat M, Perez-Piteira J, Navas-Palacios JJ. Cyclin D1 over-expression in non-small cell lung carcinoma: correlation with Ki67 labeling index and poor cytoplasmic differentiation. J Pathol 1996;180:395-399.
14. Barbieri F, Cagnoli M, Ragni N, Pedulla F, Foglia G, Alama A. Expression of cyclin D1 correlates with malignancy in human ovarian tumors. Br J Cancer 1997;75:1263-1268.
15. Volm M, Koomagi R, Mattern J, Stammler G. Cyclin A is associated with unfavourable outcome in patients with non-small cell lung carcinomas. Br J Cancer 1997;75:1774-1778.
16. UICC (International Union Against Cancer): TNM classification of malignant tumors, 3rd ed. Geneva: UICC, 1987.
17. Gleason DF and Veterans Administration Cooperative Urological Research Group. Histologic grading and staging of prostatic carcinoma. In: Tannenbaum M, editor. Urologic pathology: the prostate. Philadelphia: Lea & Febiger; 1977. p 171-187.
18. Haapasalo H, Collan Y, Pesonen E. Volume corrected mitotic index (M/V index) - the standard of mitotic activity in neoplasms. Pathol Res Pract 1989;185:551-554.
19. Lipponen P, Vesalainen S. Expression of apoptosis suppressing protein bcl-2 in prostatic adenocarcinoma is related to tumor malignancy. Prostate 1997;32:9-15.
20. Gillet CE, Smith P, Gregory WM, Richards MA, Millis RR, Peters G, Barnes DM. Cyclin D1 and prognosis in breast cancer. Int J Cancer 1996;69:92-99.
21. Tsai LH, Harlow E, Meyerson M. Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinase. Nature 1991;353:174-177.
22. Barbareschi M, Pelosio P, Caffo O, Buttitta F, Pellegrini S, Barbazza R, Dalla Palma P, Bevilacqua G, Marchetti A. Cyclin-D1-gene amplification and expression in breast carcinoma: relation with clinicopathologic characteristics and with retinoblastoma gene product, p53 and p21/waf1 immunohistochemical expression. Int J Cancer 1997;74:171-174.
23. Naitoh H, Shibata J, Kawaguchi A, Kodama M, Hattori T. Over-expression and localization of cyclin D1 mRNA and antigen in esophageal cancer. Am J Pathol 1995;146:1161-1169.
24. Frachiola NS, Pruneri G, Pignataro L, Carboni N, Capaccio P, Boletini A, Buffa R, Neri A. Molecular and immunohistochemical analysis of the bcl-1/cyclin D1 gene in laryngeal squamous cell carcinomas: correlation of protein expression with lymph node metastases and advanced clinical stage. Cancer 1997;79: 1114-1121.
25. Donnellan R, Chetty R. Cyclin D1 and human neoplasia. J Clin Pathol Mol Pathol 1998;51:1-7.
26. Michalides RJ, van-Veelen NM, Kristel PM, Hart AA, Loftus BM, Hilgers FJ, Balm JA. Over-expression of cyclin D1 indicates poor prognosis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1977;123:497-502.
27. Nakamura M, Katano M, Fujimoto K, Morisaki T. A new prognostic strategy for gastric carcinoma: mRNA expression of tumor growth-related factors in endoscopic biopsy specimens. Ann Surg 1997;226:35-42.
28. Maeda K, Chung YS, Kang SM, Ogawa M, Onoda N, Nakata B, Nishiguchi Y, Ikehar AT, Okuno M, Sowa M. Over-expression of cyclin D1 and p53 associated with disease recurrence in colorectal cancer. Int J Cancer 1997;20:310-315.
29. Velders GA, Kluin-Nelemans JC, De-Boer CL, Hermans J, Noordijk EM, Schuuring E, Kramer MH, Van-Dijk WA, Rahder JB, Kluin PM, Van-Krieken JH. Mantle-cell lymphoma: a population-based clinical study. J Clin Oncol 1996;14:1269-1274.
30. Mashal RD, Lester S, Corless C, Richie JP, Chandra R, Propert KJ, Dutta A. Expression of cell cycle-regulated proteins in prostate cancer. Cancer Res 1996;56:4159-4163.